Lung - Cancer
The role of surgery in locally advanced non-small cell lung cancer (NSCLC) is continuously evolving with the introduction of effective neoadjuvant systemic treatments. Beyond tumor reduction, treatment response may influence surgical decision-making by improving resectability...
This case report describes a 75-year-old patient with a centrally located squamous cell carcinoma extending from the carina to the right intermediate bronchus and the superior segment of the lower...
This Society of Thoracic Surgeons General Thoracic Surgery Database analysis found that postoperative chylothorax risk increases with the extent of lymph-node dissection during pulmonary resection. Although uncommon, chylothorax was associated...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...
High tumor mutational burden (TMB) predicts not only response to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) but also immune-related toxicity. In this single-center cohort of...
